Conversely, overexpression of PON2 is associated with aggressive phenotypes and poor prognosis in melanoma, bladder carcinoma, and basal cell carcinoma (Bacchetti et al. 2017, 2021). This evidence concerns the gene PON2 and urinary bladder carcinoma.